WestEnd Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3K | Buy |
77
+8
| +12% | +$1.49K | ﹤0.01% | 73 |
|
|
2025
Q1 | $14.5K | Buy |
69
+19
| +38% | +$3.98K | ﹤0.01% | 69 |
|
|
2024
Q4 | $8.88K | Sell |
50
-2
| -4% | -$355 | ﹤0.01% | 74 |
|
|
2024
Q3 | $10.2K | Sell |
52
-2
| -4% | -$391 | ﹤0.01% | 67 |
|
|
2024
Q2 | $9.18K | Sell |
54
-7
| -11% | -$1.19K | ﹤0.01% | 66 |
|
|
2024
Q1 | $11K | Sell |
61
-452
| -88% | -$81.6K | ﹤0.01% | 63 |
|
|
2023
Q4 | $79.4K | Sell |
513
-127,663
| -100% | -$19.8M | ﹤0.01% | 51 |
|
|
2023
Q3 | $19.1M | Buy |
128,176
+29,506
| +30% | +$4.4M | 0.57% | 34 |
|
|
2023
Q2 | $13.3M | Buy |
+98,670
| New | +$13.3M | 0.39% | 37 |
|
|
2023
Q1 | – | Sell |
-113,179
| Closed | -$18.3M | – | 35 |
|
|
2022
Q4 | $18.3M | Buy |
113,179
+2,338
| +2% | +$378K | 0.6% | 36 |
|
|
2022
Q3 | $14.9M | Sell |
110,841
-11,043
| -9% | -$1.48M | 0.5% | 36 |
|
|
2022
Q2 | $18.7M | Buy |
+121,884
| New | +$18.7M | 0.59% | 34 |
|
|
2022
Q1 | – | Sell |
-13
| Closed | -$1.76K | – | 75 |
|
|
2021
Q4 | $1.76K | Buy |
+13
| New | +$1.76K | ﹤0.01% | 83 |
|
|
2021
Q3 | – | Hold |
0
| – | -$1.58M | – | 87 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 76 |
|